By MARI YAMAGUCHI. Associated Press...The draft budget for fiscal 2026 beginning April is up 9.4% from 2025 and marks the fourth year of Japan’s ongoing five-year program to double annual arms spending to 2% of gross domestic product ... Tension wit ... .
Marking the first full-year spending plan since Takaichi took office in October, the budget bill is expected to clear the Diet by the end of the current fiscal year. Prime MinisterSanae Takaichi arrives at the premier's office in Tokyo on Dec ... ....
U.S. regulators gave the green light Monday to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity ... .
ChristianFiscal Court has approved the adoption of a resolution related to legislative priorities that local officials will be advocating for during upcoming visits in Frankfort ... .
NJ bill would allow nonprofits to sell property to housing developers. By allowing nonprofits and religious groups to sell property, some hope to ease NJ affordable housing crisis ... 22 meeting ... permitting ... 31 ... No plans were included with the borough's Dec.
Share Share by..Copy link. Facebook. X. Whatsapp. Flipboard ... “They found out where I was, and I was drunk, but I told them, ‘I’ll meet the players in Seville and I’ll play against Maradona, OK.’Get FourFourTwo Newsletter ... ....
DEAR ABBY. While attending a friend’s family barbecue, “Willa,” a young mother of four, drank too much and became ill. Drugs may have been involved. Understandably, the three older children became very concerned about their mom’s condition ... DEAR READERS.
NJ affordable housing history. Video. Take a look at North Jersey’s history with affordable housing over the last 50 years ...Contamination there is well-documented, and officials stressed that the property must be cleaned to a livable standard ... 29 ... Email.
Novo NordiskA/S won approval to sell a pill version of its blockbuster obesity shot Wegovy in the United States, a crucial step in its effort to defend its market share from rival Eli Lilly & Co ... .